Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy Among Patients 75 Years or Older
JAMA Cardiology Author Interviews
00:00
Safety Findings in Older Patients
Bach and Gotto report no increased myopathy, liver, cognitive, or cancer signals with ezetimibe plus simvastatin in elders.
Play episode from 16:28
Transcript
